Nehme Melhem's avatarPerson

Nehme Melhem

President and Group Executive ChairmanMelhem Holdings

Washington, DC

Skills

Executive Leadership
Artificial Intelligence

About

Nehme Gerges Melhem is a global health innovator, researcher, and philanthropist committed to advancing medical research, education, and equitable access to care worldwide. Through his leadership of Melhem Scientific, Melhem Pharmaceuticals and the Melhem Foundation, he fosters strategic partnerships that connect scientists, clinicians, and humanitarian organizations, integrating innovation with compassionate care delivery. His work spans multiple regions, supporting under-resourced researchers, strengthening medical outreach initiatives, and advancing scientific diplomacy through collaborative research and global health programs. Drawing on personal resilience shaped by lived experiences with adversity and mental health challenges, Mr. Melhem brings an empathetic, purpose-driven approach to leadership and remains dedicated to improving health outcomes while inspiring the next generation of changemakers.

Company details

Melhem Holdings

Company bio

Melhem Holdings serves as the parent organization and strategic umbrella for the portfolio of entities established by Nehme Gerges Melhem. The holding company provides unified governance, long-term strategic direction, and operational infrastructure to support a diverse ecosystem spanning investments, scientific innovation, healthcare, pharmaceuticals, technology, and global impact initiatives. Through its subsidiaries, Melhem Scientific, Melhem Pharmaceuticals, Melhem Consultancy, Melhem Foundation, and Melhem Investments. Melhem Holdings promotes cross-sector collaboration, sustainable growth, and integrated solutions that bridge research, industry, and global health priorities. Collectively, these entities advance scientific research and medical innovation; develop healthcare and pharmaceutical solutions; deliver strategic advisory and organizational development services; fund humanitarian and educational initiatives; and invest in high-impact ventures. Together, they aim to accelerate discovery, expand equitable access to care, strengthen institutional capacity, and generate measurable social and economic impact worldwide.

Area of focus

Pharmaceutical
Medical
Education

Company size

51 - 200